Ulesfia Topical Lotion 5pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Ulesfia: Topical lotion (5%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Ulesfia 5% Top Lotion
Drug Image file default-drug-image.png
Ulesfia 5% Top Lotion
Drug Image file default-drug-image.png
Ulesfia 5% Top Lotion

What is this Medicine?

BENZYL ALCOHOL (BEN zil AL kuh hawl) lotion is used to treat lice of the hair and scalp. It acts by destroying the lice. It does not destroy their eggs; a second treatment is needed 7 days after the first treatment.

CVS Pharmacy Patient Statistics for Ulesfia: Topical lotion(5%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Ulesfia 2-Pack 5% Topical Lotion

NDC: 235940780
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pediculosis

Storage Information
Store in a dry place
Do not freeze
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Ulesfia 2-Pack 5% Topical Lotion

Reported Side Effects for Ulesfia 2-Pack 5% Topical Lotion

Allergic Skin Reaction Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Dry Skin Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Hyperesthesia Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Hypoesthesia Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
6.0%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
7.0-10.0%*
Severity: MODERATE
Onset: EARLY
Itching Incidence:
12.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ulesfia

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5